Table 3 Adverse reactions (n = 43)
Grade | ||||||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | Total | ||
n | n | n | n | n | (%) | |
Hematological toxicities | ||||||
Neutropenia | 7 | 8 | 1 | 0 | 19 | (44.2%) |
Leukopenia | 5 | 21 | 2 | 0 | 28 | (65.1%) |
Thrombocytopenia | 13 | 0 | 0 | 0 | 13 | (30.2%) |
Anemia (Hb) | 11 | 3 | 0 | 0 | 14 | (32.6%) |
AST | 12 | 0 | 0 | 0 | 12 | (27.9%) |
ALT | 11 | 0 | 0 | 0 | 11 | (25.6%) |
Total bilirubin | 7 | 1 | 0 | 0 | 8 | (18.6%) |
Creatinine | 2 | 0 | 0 | 0 | 2 | (4.6%) |
Non-hematological toxicities | ||||||
Anorexia | 24 | 4 | 0 | 0 | 28 | (65.1%) |
General Fatigue | 29 | 2 | 0 | 0 | 31 | (72.1%) |
Diarrhea | 13 | 0 | 2 | 0 | 15 | (34.9%) |
Nausea | 12 | 4 | 0 | 0 | 16 | (37.2%) |
Stomatitis | 15 | 1 | 0 | 0 | 16 | (37.2%) |
Pigmentation changes | 17 | 3 | 0 | 0 | 20 | (46.5%) |
Rash | 3 | 1 | 0 | 0 | 4 | (9.3%) |